NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Stock Information | RedChip

NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Listen to this Section


$1.75
+0.0100 ( +0.58% ) 62.5K

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market Data


Open


$1.75

Previous close


$1.74

Volume


62.5K

Market cap


$18.51M

Day range


$1.74 - $1.95

52 week range


$1.73 - $7.33

Insider Ownership Transactions

Total Amount Purchased: 405,000.00 | $ 708,750.00

Date Type Amount Purchased Purchaser
2023-09-11 Buy 70000.00 Hurvitz Chaim
2023-09-11 Buy 35000.00 Gorovitz Aaron
2023-08-24 Buy 100000.00 Javitt Jonathan C
2023-08-23 Buy 200000.00 Javitt Jonathan C

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 20 Aug 15, 2024
10-q Quarterly Reports 71 Aug 14, 2024
8-k 8K-related 25 Aug 14, 2024
8-k 8K-related 14 Aug 12, 2024
8-k 8K-related 14 Jun 27, 2024
3 Insider transactions 1 Jun 26, 2024
8-k 8K-related 15 Jun 20, 2024
8-k 8K-related 15 May 23, 2024
8-k 8K-related 17 May 16, 2024
10-q Quarterly Reports 84 May 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.